Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin vs Pirarubicin in Locally Advanced Breast Cancer
NCT02903524Phase 4Unknown
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by The Fourth Hospital of Hebei Medical University. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02903524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903524.